Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.

Georg GelbeneggerMarek PostulaLadislav PecenSigrun HalvorsenMaciej LesiakChristian SchoergenhoferBernd JilmaChristian HengstenbergJolanta M Siller-Matula

Published in: BMC medicine (2019)

PROSPERO CRD42019118474.

Keyphrases

cardiovascular disease
cardiovascular events
low dose
antiplatelet therapy
type diabetes
cardiovascular risk factors
coronary artery disease
percutaneous coronary intervention
atrial fibrillation